BioLineRx (BLRX) Receivables - Other (2010 - 2026)
BioLineRx (BLRX) posted quarterly Receivables - Other of $410000.0 for Q4 2025, down 72.26% year-over-year from $1.5 million in Q4 2024, and down 41.34% quarter-over-quarter from $699000.0 in Q3 2025.
Powered by 
Analysis
BioLineRx (BLRX) Receivables - Other (2010 - 2026) Analysis & Trends
BioLineRx's Receivables - Other history runs 16 years deep, the most recent figure standing at $410000.0 for Q4 2025.
- In Q4 2025, Receivables - Other fell 72.26% year-over-year to $410000.0; the TTM figure through Dec 2025 stood at $410000.0 (down 72.26% YoY), while the FY2025 annual figure was $410000.0, down 72.26% from the prior year.
- Receivables - Other for Q4 2025 stood at $410000.0, down from $699000.0 in the prior quarter.
- The five-year high for Receivables - Other was $2.4 million in Q2 2025, with the low at $128000.0 in Q2 2023.
- The 5-year median for Receivables - Other is $380000.0 (2024), against an average of $550650.0.
- The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 412.5% in 2024, then tumbled 72.26% in 2025.
- BioLineRx's Receivables - Other stood at $142000.0 in 2021, then soared by 407.75% to $721000.0 in 2022, then increased by 15.12% to $830000.0 in 2023, then jumped by 78.07% to $1.5 million in 2024, then sank by 72.26% to $410000.0 in 2025.
- Business Quant data shows BLRX's Receivables - Other at $410000.0 in Q4 2025, $699000.0 in Q3 2025, and $2.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | BioLineRx | 6.64 Bn | 6.64 Bn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 728,000.00 |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 456,000.00 |
| Sep 30, 2025 | 699,000.00 |
| Jun 30, 2025 | 203,000.00 |
| Mar 31, 2025 | 452,000.00 |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | 656,000.00 |
| Mar 31, 2024 | 507,000.00 |
| Dec 31, 2023 | 830,000.00 |
| Sep 30, 2023 | 315,000.00 |
| Jun 30, 2023 | 128,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Dec 31, 2022 | 721,000.00 |
| Sep 30, 2022 | 143,000.00 |
| Jun 30, 2022 | 240,000.00 |
| Mar 31, 2022 | 190,000.00 |
| Dec 31, 2021 | 142,000.00 |
| Sep 30, 2021 | 192,000.00 |